Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent.

Xiang M, Kim H, Ho VT, Walker SR, Bar-Natan M, Anahtar M, Liu S, Toniolo PA, Kroll Y, Jones N, Giaccone ZT, Heppler LN, Ye DQ, Marineau JJ, Shaw D, Bradner JE, Blonquist T, Neuberg D, Hetz C, Stone RM, Soiffer RJ, Frank DA.

Blood. 2016 Oct 6;128(14):1845-1853. doi: 10.1182/blood-2015-07-660506. Epub 2016 Aug 16.

2.

Young investigator challenge: Application of cytologic techniques to circulating tumor cell specimens: Detecting activation of the oncogenic transcription factor STAT3.

Lowe AC, Pignon JC, Carvo I, Drage MG, Constantine NM, Jones N, Kroll Y, Frank DA, Signoretti S, Cibas ES.

Cancer Cytopathol. 2015 Dec;123(12):696-706. doi: 10.1002/cncy.21640.

3.

STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypes.

Xiang M, Birkbak NJ, Vafaizadeh V, Walker SR, Yeh JE, Liu S, Kroll Y, Boldin M, Taganov K, Groner B, Richardson AL, Frank DA.

Sci Signal. 2014 Jan 28;7(310):ra11. doi: 10.1126/scisignal.2004497.

4.

Occlusal trauma. An evaluation of its relationship to periodontal prostheses.

Wank GS, Kroll YJ.

Dent Clin North Am. 1981 Jul;25(3):511-32. Review.

PMID:
7021239
5.

Ascorbic acid inhibition of cyclic nucleotide phosphodiesterase acitivity.

Malamud D, Kroll Y.

Proc Soc Exp Biol Med. 1980 Sep;164(4):534-6. No abstract available.

PMID:
6251481

Supplemental Content

Support Center